These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

678 related items for PubMed ID: 9360162

  • 1. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
    Tao W, Deyo DJ, Brunston RL, Vertrees RA, Grochoske TL, Zwischenberger JB.
    ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Flow rate dependent ex vivo deheparinization with immobilized cationic ligand.
    Tevaearai HT, Mueller XM, Marty B, Horisberger J, Schapira M, von Segesser LK.
    ASAIO J; 1997; 43(5):M487-9. PubMed ID: 9360090
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP, Haddon WS, Rothberger HK, Mills SA, Rogers AT, Bean VE, Buss DH, Prough DS, Cordell AR.
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
    [Abstract] [Full Text] [Related]

  • 6. Reversal of anticoagulation without protamine using a heparin removal device after cardiopulmonary bypass.
    Vertress RA, Zwischenberger JB, McRea JC, Tao W, Kurusz M, Conti VR.
    ASAIO J; 1994 Mar; 40(3):M560-4. PubMed ID: 8555577
    [Abstract] [Full Text] [Related]

  • 7. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M, Velik-Salchner C, Stalzer B, Margreiter J, Klingler A, Streif W, Fries D, Innerhofer P.
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Randomized trial of recombinant platelet factor 4 versus protamine for the reversal of heparin anticoagulation in humans.
    Dehmer GJ, Lange RA, Tate DA, Pirwitz M, Daniel W, Fisher M, Bonnem EM.
    Circulation; 1996 Nov 01; 94(9 Suppl):II347-52. PubMed ID: 8901773
    [Abstract] [Full Text] [Related]

  • 18. [The impact of heparin bolus from dysfunctional lumen of dual lumen central venous catheter on activated partial thromboplastin time during hemodialysis: is additional heparinization necessary?].
    Sefer S, Kes P, Raić B, Heinrich B, Degoricija V, Szavits-Nossan J.
    Acta Med Croatica; 2006 Jun 01; 60(3):281-5. PubMed ID: 16933844
    [Abstract] [Full Text] [Related]

  • 19. Significant reduction in circuit pressure with modified plasma separation chamber for a heparin removal device.
    Tao W, Deyo DJ, Alpard SK, Vertrees RA, Hoang V, Zwischenberger JB.
    ASAIO J; 1999 Jun 01; 45(1):50-2. PubMed ID: 9952007
    [Abstract] [Full Text] [Related]

  • 20. Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass.
    Cavarocchi NC, Schaff HV, Orszulak TA, Homburger HA, Schnell WA, Pluth JR.
    Surgery; 1985 Sep 01; 98(3):525-31. PubMed ID: 3875906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.